BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37641533)

  • 1. Immunoglobulin A Glycosylation Differs between Crohn's Disease and Ulcerative Colitis.
    Clerc F; Reiding KR; de Haan N; Koeleman CAM; Hipgrave Ederveen AL; Manetti N; ; Dotz V; Annese V; Wuhrer M
    J Proteome Res; 2023 Oct; 22(10):3213-3224. PubMed ID: 37641533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylation of Immunoglobulin G Associates With Clinical Features of Inflammatory Bowel Diseases.
    Šimurina M; de Haan N; Vučković F; Kennedy NA; Štambuk J; Falck D; Trbojević-Akmačić I; Clerc F; Razdorov G; Khon A; Latiano A; D'Incà R; Danese S; Targan S; Landers C; Dubinsky M; ; McGovern DPB; Annese V; Wuhrer M; Lauc G
    Gastroenterology; 2018 Apr; 154(5):1320-1333.e10. PubMed ID: 29309774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma N-Glycan Signatures Are Associated With Features of Inflammatory Bowel Diseases.
    Clerc F; Novokmet M; Dotz V; Reiding KR; de Haan N; Kammeijer GSM; Dalebout H; Bladergroen MR; Vukovic F; Rapp E; ; Targan SR; Barron G; Manetti N; Latiano A; McGovern DPB; Annese V; Lauc G; Wuhrer M
    Gastroenterology; 2018 Sep; 155(3):829-843. PubMed ID: 29792883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
    Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
    World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Levels of Anti-Citrullinated Protein Antibodies and Rheumatoid Factor, Including IgA Isotypes, and Articular Manifestations in Ulcerative Colitis and Crohn's Disease.
    Janssen KMJ; Hop H; Vissink A; Dijkstra G; de Smit MJ; Brouwer E; Westra J
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33139618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in incidence and clinical features of inflammatory bowel disease in Cardiff, UK over 50 years: an update for 2005-2016.
    Arms-Williams B; Hawthorne AB; Cannings-John R; Berry A; Harborne P; Trivedi A
    Scand J Gastroenterol; 2023 Jun; 58(6):619-626. PubMed ID: 36562277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.
    Sipeki N; Davida L; Palyu E; Altorjay I; Harsfalvi J; Szalmas PA; Szabo Z; Veres G; Shums Z; Norman GL; Lakatos PL; Papp M
    World J Gastroenterol; 2015 Jun; 21(22):6952-64. PubMed ID: 26078573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Location-based prediction model for Crohn's disease regarding a novel serological marker, anti-chitinase 3-like 1 autoantibodies.
    Sipeki N; Kovats PJ; Deutschmann C; Schierack P; Roggenbuck D; Papp M
    World J Gastroenterol; 2023 Nov; 29(42):5728-5750. PubMed ID: 38075846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.
    Quaglio AEV; Santaella FJ; Rodrigues MAM; Sassaki LY; Di Stasi LC
    World J Gastroenterol; 2021 Dec; 27(45):7801-7812. PubMed ID: 34963743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
    Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
    Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological profiling of Crohn's disease and ulcerative colitis patients reveals anti-microbial antibody signatures.
    Shome M; Song L; Williams S; Chung Y; Murugan V; Park JG; Faubion W; Pasha SF; Leighton JA; LaBaer J; Qiu J
    World J Gastroenterol; 2022 Aug; 28(30):4089-4101. PubMed ID: 36157118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of inflammatory bowel disease in the Australian general practice population: A cross-sectional study.
    Busingye D; Pollack A; Chidwick K
    PLoS One; 2021; 16(5):e0252458. PubMed ID: 34043730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finger clubbing in inflammatory bowel disease: association with upper small bowel lesions and need of surgery in Crohn's disease.
    Romeo S; Neri B; Mossa M; Calabrese E; Lolli E; Sena G; Gesuale C; Chiaramonte C; Biancone L
    Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):844-851. PubMed ID: 33136723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino acids-targeted metabolomics reveals novel diagnostic biomarkers for ulcerative colitis and Crohn's disease.
    Zhou G; Liu H; Wei P; He Q; Zhang J; Shi Q; Liu T; Liu S
    Amino Acids; 2023 Mar; 55(3):349-358. PubMed ID: 36625991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's disease.
    Inoue T; Iijima H; Tajiri M; Shinzaki S; Shiraishi E; Hiyama S; Mukai A; Nakajima S; Iwatani H; Nishida T; Mizushima T; Yasui T; Isaka Y; Kanto T; Tsujii M; Miyoshi E; Wada Y; Takehara T
    Inflamm Bowel Dis; 2012 Sep; 18(9):1723-34. PubMed ID: 22241690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry.
    Shapiro JM; Zoega H; Shah SA; Bright RM; Mallette M; Moniz H; Grabert SA; Bancroft B; Merrick M; Flowers NT; Samad Z; Lidofsky S; LeLeiko NS; Sands BE
    Inflamm Bowel Dis; 2016 Jun; 22(6):1456-61. PubMed ID: 26926039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory Bowel Disease as a Precondition for Stroke or TIA: A Matter of Crohn's Disease Rather than Ulcerative Colitis.
    Tanislav C; Trommer K; Labenz C; Kostev K
    J Stroke Cerebrovasc Dis; 2021 Jul; 30(7):105787. PubMed ID: 33865232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.